Last reviewed · How we verify

ProRoot MTA — Competitive Intelligence Brief

ProRoot MTA (ProRoot MTA) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Endodontic cement / Mineral trioxide aggregate. Area: Dentistry / Endodontics.

marketed Endodontic cement / Mineral trioxide aggregate Dentistry / Endodontics Small molecule Live · refreshed every 30 min

Target snapshot

ProRoot MTA (ProRoot MTA) — University of the Pacific. ProRoot MTA is a mineral trioxide aggregate (MTA) cement that sets through a hydration reaction to form a biocompatible seal in endodontic applications.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ProRoot MTA TARGET ProRoot MTA University of the Pacific marketed Endodontic cement / Mineral trioxide aggregate

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Endodontic cement / Mineral trioxide aggregate class)

  1. University of the Pacific · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ProRoot MTA — Competitive Intelligence Brief. https://druglandscape.com/ci/proroot-mta. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: